Hostname: page-component-7bb8b95d7b-dvmhs Total loading time: 0 Render date: 2024-09-18T15:07:50.068Z Has data issue: false hasContentIssue false
  • English
  • Français

Cognitive–Behavioral and Psychopharmacological Treatment of Delusional Symptoms: A Preliminary Report

Published online by Cambridge University Press:  16 June 2009

Lorne M. Hartman  and
Frank E. Cashman
Lorne M. Hartman
Affiliation:
Clarke Institute of Psychiatry, Toronto, Canada
Frank E. Cashman
Affiliation:
University of Toronto, Toronto, Canada
Get access Rights & Permissions [Opens in a new window]

Extract

Several psychopathological conditions include delusional beliefs as central symptoms. A conceptual model highlighting the importance of cognitive factors in regulating the bizarre internal contingencies which characterize delusional systems is presented. Cognitive–behavioral treatment emphasizes the direct modification of expectations and beliefs as well as the disordered behavior patterns they support. The efficacy of neuroleptics in treating delusional states has also been reported. Two patients with predominate delusional beliefs were treated in a cross-over design by the sequential use of cognitive–behavior therapy and pimozide. A third patient received cognitive–behavioral training alone. The delusions as well as the anxiety associated with them diminished and behavioral functioning improved significantly following cognitive therapy. The relationship between delusional symptoms, perceptions of self, and social functioning, as well as the optimal application of cognitive–behavioral and psychopharmacological interventions are discussed.

Type
Research Article
Information
Behavioural and Cognitive Psychotherapy , Volume 11 , Issue 1 , January 1983 , pp. 50 - 61
Copyright
Copyright © British Association for Behavioural and Cognitive Psychotherapies 1983

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bandura, A. (1977). Self-efficacy: Towards a unifying theory of behavioral change. Psychological Review 84, 191–215.CrossRefGoogle Scholar
Beck, A. T., Rush, A. J., Shaw, B. F. and Emery, G. (1979). Cognitive Therapy of Depression. New York: Guilford Press.Google Scholar
Cautela, J. R. (1979). Behaviour Analysis Forms for Clinical Intervention. Champaign, Illinois: Research Press.Google Scholar
Ellis, A. (1962). Reason and Emotion in Psychotherapy. New York: Stuart.Google Scholar
Falloon, I., Watt, D. C. and Sheperd, M. (1978). A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia. Psychological Medicine 8, 59–70.CrossRefGoogle ScholarPubMed
Jimerson, D. C., Post, R. M., Skyler, J. and Bunney, W. E. (1976). Prolactin in cerebrospinal fluid and dopamine function in men. Pharmacology 28, 845–846.Google Scholar
Kiesler, D. J. (1971). Experimental designs in psychotherapy research. In Handbook of Psychotherapy and Behavior Change. Bergin, A. E. and Garfield, S. L. (Eds), New York: Wiley.Google Scholar
Lehmann, H. E., Hock, P. and Zubin, J. (1966). Psychopathology of Schizophrenia. New York: Grune.Google Scholar
Meichenbaum, D. (1977). Cognitive–behavior Modification: An Integrative Approach, New York: Plenum Press.CrossRefGoogle Scholar
Milton, F., Patwa, V. K. and Hafner, J. (1978). Confrontation vs. belief modification in persistently deluded patients. British Journal of Medical Psychology 51, 127–130.CrossRefGoogle ScholarPubMed
Munroe, A. (1978a). Monosymptomatic hypochondriacal psychosis. Canadian Journal of Psychiatry 23, 497–500.Google Scholar
Munroe, A. (1978b). Two cases of delusions of worm infestation. American Journal of Psychiatry 135, 234–235.Google Scholar
Pinder, R. M., Brogden, R. N., Sawyer, T. M., Speight, B. and Avery, G. S. (1976). Pimozide: A review of its pharmacological properties and therapeutic uses in psychiatry. Drugs 12, 1–40.CrossRefGoogle ScholarPubMed
Piyakulmala, S., Corbett, L., Akluwalia, Y., Berry, R. A. and Meltzer, H. Y. (1977). High dose pimozide in the treatment of acutely agitated schizophrenia. Current Therapeutic Research, Clinical and Experimental 22, 453–461.Google Scholar
Rachman, S. (1976). The modification of obsessions: A new formulation. Behaviour Research and Therapy 14, 437–443.CrossRefGoogle ScholarPubMed
Reilly, T. M., Jopling, W. H. and Beard, A. W. (1978). Successful treatment of delusional parasitosis. British Journal of Dermatology 98, 457–459.CrossRefGoogle ScholarPubMed
Riding, J. and Munro, A. (1975). Pimozide in the treatment of monosymptomatic hypochondriacal psychosis. Acta Psychiatrica Scandinavica 52, 23–30.CrossRefGoogle ScholarPubMed
Ross, M. S. and Moldofsky, H. (1978). A comparison of pimozide and haloperidol in the treatment of Gilles de La Tourette's syndrome. American Journal of Psychiatry 135, 585–587.Google ScholarPubMed
Schwartz, G. E., Davidson, R. J. and Goleman, D. (1978). Patterning of cognitive and somatic processes in the self-regulation of anxiety. Psychosomatic Medicine 40, 321–328.CrossRefGoogle ScholarPubMed
Shopsin, B. and Selzer, G. (1977). High dose pimozide in acutely ill, newly admitted schizophrenic patients. Current Therapeutic Research, Clinical and Experimental 21, 321–328.Google Scholar
Watts, F. N., Powell, G. E., and Austin, S. V. (1973). The modification of abnormal beliefs. British Journal of Medicinal Psychology 46, 359–363.CrossRefGoogle ScholarPubMed
Zuckerman, M. and Lubin, B. (1965). The multiple affect adjective checklist. San Diego: The Educational and Industrial Testing Service.Google Scholar
Submit a response

Comments

No Comments have been published for this article.